Literature DB >> 31036453

Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.

S Ortega-Vargas1, C Espitia2, A Sahagún-Ruiz3, C Parada2, A Balderas-Loaeza4, A Villa-Mancera5, H Quiroz-Romero4.   

Abstract

Leucine aminopeptidase (FhLAP) and cathepsin L1 (FhCL1) of Fasciola hepatica play a critical role in parasite feeding, migration through host tissue, and immune evasion. These antigens have been tested for immune protection as single components with variable degrees of success. The chimeric-protein approach could improve protection levels against fasciolosis. Previously, we reported the design and construction of a chimeric protein composed of antigenic sequences of FhLAP and FhCL1 of F. hepatica. The goal of the present study was to express and evaluate the immune-protective capacity of this chimeric protein (rFhLAP-CL1) in sheep. Animals were randomly allocated into five groups with five animals in each group. Groups 1, 2 and 3 were immunized twice with 100 μg, 200 μg and 400 μg of rFhLAP-CL1 emulsified with Quil A adjuvant, whereas groups 4 and 5 were the adjuvant control and infection control groups, respectively. The animals were then challenged with 200 metacercariae two weeks after the rFhLAP-CL1 booster. The fluke burden was reduced by 25.5%, 30.7% (p < 0.05) and 46.5% (p < 0.01) in sheep immunized with 100 μg, 200 μg and 400 μg of chimeric protein, respectively, in comparison to the infection control group. There was a reduction of 22.7% (p < 0.05) and 24.4% (p < 0.01) in fecal egg count in groups 2 and 3, respectively, compared to the infection control group. Sheep immunized with chimeric protein produced F. hepatica excretion-secretion product-specific total IgG antibody, which were increased after challenge. Moreover, the levels of rFhLAP-CL1-specific IgG1 and IgG2 isotypes in immunized sheep increased rapidly two weeks after the first immunization and were significantly more elevated than those of the control groups, indicating a mixed Th1/Th2 response. This is a preliminary evaluation of the chimeric protein rFhLAP-CL1 as a possible immunogen against F. hepatica infection in sheep.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chimeric protein; Fasciola hepatica; Immunization; Sheep

Year:  2019        PMID: 31036453     DOI: 10.1016/j.vaccine.2019.04.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.

Authors:  Luyen Thi Phung; Sujittra Chaiyadet; Nuttanan Hongsrichan; Javier Sotillo; Hang Dinh Thi Dieu; Canh Quang Tran; Paul J Brindley; Alex Loukas; Thewarach Laha
Journal:  Acta Trop       Date:  2020-01-25       Impact factor: 3.112

Review 2.  Helminth Vaccines in Ruminants: From Development to Application.

Authors:  Edwin Claerebout; Peter Geldhof
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-03       Impact factor: 3.357

3.  Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep.

Authors:  Rafael Zafra; Leandro Buffoni; Raúl Pérez-Caballero; Verónica Molina-Hernández; María T Ruiz-Campillo; José Pérez; Álvaro Martínez-Moreno; Francisco J Martínez Moreno
Journal:  Vet Res       Date:  2021-01-28       Impact factor: 3.683

4.  Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.

Authors:  Leandro Buffoni; Laura Garza-Cuartero; Raúl Pérez-Caballero; Rafael Zafra; F Javier Martínez-Moreno; Verónica Molina-Hernández; José Pérez; Álvaro Martínez-Moreno; Grace Mulcahy
Journal:  Parasit Vectors       Date:  2020-07-31       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.